SI
DGX icon

Sentry Investments’s Quest Diagnostics DGX Stock Holding History

Sentry Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-133,300
Closed -$8.09M – 154
2014
Q3 		$8.09M Sell
133,300
-429,583
-76% -$26.5M 0.1% 116
2014
Q2 		$33M Buy
562,883
+105,000
+23% +$6.15M 0.41% 68
2014
Q1 		$26.5M Buy
457,883
+51,000
+13% +$2.73M 0.38% 71
2013
Q4 		$21.8M Sell
406,883
-557,500
-58% -$33.1M 0.37% 75
2013
Q3 		$59.6M Sell
964,383
-417,417
-30% -$25M 1.15% 26
2013
Q2 		$83.8M Buy
+1,381,800
New +$82.3M 1.8% 12

Other funds holding DGX

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Sentry Investments's DGX Position: Q4 2014 in Review

Sentry Investments sold out of Quest Diagnostics (DGX) in Q4 2014, closing a stake of 133,300 shares — an estimated $8.09M sold.

Sentry Investments first reported a position in DGX in Q2 2013 and held it in 6 quarters. The position peaked at $83.8M in Q2 2013. 517 funds tracked by Wall St. Rank hold DGX as of Q4 2014.

  • Sentry Investments reported no remaining Quest Diagnostics position as of Q4 2014 after selling out during the quarter.
  • Sentry Investments sold 133,300 Quest Diagnostics shares in Q4 2014, an estimated $8.09M.
  • Sentry Investments first reported a position in Quest Diagnostics in Q2 2013 and held it in 6 quarters.
  • Sentry Investments's Quest Diagnostics position peaked at $83.8M in Q2 2013.
  • 517 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2014.

Based on Sentry Investments's 13F filing for Q4 2014, filed 13 Feb 2015.